Full Text View
Tabular View
No Study Results Posted
Related Studies
A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen
This study has been withdrawn prior to recruitment.
Study NCT00319332   Information provided by GlaxoSmithKline
First Received: April 26, 2006   Last Updated: January 24, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial